Gene · 2131
Papers1,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-diabetic urine glucose in idiopathic membranous nephropathy. | Ren Fail | 2022 | 35820795 | PubTator, text mining | PubMed |
| EXTL3 could serve as a potential biomarker of prognosis and immunotherapy for prostate cancer and its potential mechanisms. | Eur J Med Res | 2022 | 35818069 | PubTator, text mining | PubMed |
| Aptamer-Based Proteomic Platform for Human Immune-Mediated Kidney Diseases. | Kidney Int Rep | 2022 | 35812268 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| An integrative pan-cancer analysis of the molecular and biological features of glycosyltransferases. | Clin Transl Med | 2022 | 35808804 | PubTator, text mining | PubMed |
| Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer. | Molecules | 2022 | 35807355 | PubTator, text mining | PubMed |
| A Genotype-Phenotype Study of Multiple Hereditary Exostoses in Forty-Three Patients. | J Clin Med | 2022 | 35806987 | PubTator, text mining | PubMed |
| Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors. | Oncogene | 2022 | 35798875 | PubTator, text mining | PubMed |
| Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo models. | Life Sci Alliance | 2022 | 35790300 | PubTator, text mining | PubMed |
| Total Knee Arthroplasty With Patient-Specific Instrumentation to Correct Severe Valgus Deformity in a Patient With Hereditary Multiple Exostoses. | Arthroplast Today | 2022 | 35789783 | PubTator, text mining | PubMed |
| Long Intergenic Noncoding RNA MIAT as a Regulator of Human Th17 Cell Differentiation. | Front Immunol | 2022 | 35784351 | PubTator, text mining | PubMed |
| Correction: Exostosin glycosyltransferase 1 reduces porcine reproductive and respiratory syndrome virus infection through proteasomal degradation of nsp3 and nsp5. | J Biol Chem | 2022 | 35777197 | PubTator, text mining | PubMed |
| A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma. | Front Genet | 2022 | 35774514 | PubTator, text mining | PubMed |
| Differentially methylated and expressed genes in familial type 1 diabetes. | Sci Rep | 2022 | 35773317 | PubTator, text mining | PubMed |
| Synthetic Vulnerabilities in the KRAS Pathway. | Cancers (Basel) | 2022 | 35740503 | PubTator, text mining | PubMed |
| Real-World Data and Budget Impact Analysis (BIA): Evaluation of a Targeted Next-Generation Sequencing Diagnostic Approach in Two Orthopedic Rare Diseases. | Front Pharmacol | 2022 | 35734413 | PubTator, text mining | PubMed |
| Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature. | Front Immunol | 2022 | 35720299 | PubTator, text mining | PubMed |
| A frameshift variant in the EXT1 gene in a feline leukemia virus-negative cat with osteochondromatosis. | Anim Genet | 2022 | 35719100 | PubTator, text mining | PubMed |
| Identification of Heparan Sulfate in Dilated Cardiomyopathy by Integrated Bioinformatics Analysis. | Front Cardiovasc Med | 2022 | 35711374 | PubTator, text mining | PubMed |
| HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC). | BMC Med Genomics | 2022 | 35710421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2131/papers?page=19